Retrospective study of peptide receptor radionuclide therapy for Japanese patients with advanced neuroendocrine tumors.
Noritoshi KobayashiDamian WildFelix KaulTakeshi ShimamuraShoko TakanoYuma TakedaNaoki OkuboAkihiro SuzukiMotohiko TokuhisaYasushi IchikawaPublished in: Journal of hepato-biliary-pancreatic sciences (2021)
PRRT was effective and safe for Japanese patients with advanced NETs. PRRT was equally effective as front-line and late-line treatment.
Keyphrases